Amphia Hospital — Clinical Trial Site

190 Registered trials

65 Currently recruiting

Organisation

Amphia Hospital

Location

Breda, Netherlands

Identifier

ORG-100029470

Address

Molengracht 21, 4818 CK, Netherlands

Departments

#40351: Dermatology
#5004:Dermatology
031003: Pediatrics
2601:Cardiology
4901:Pulmonology
5002: Lung Disease and Tuberculosis
5003: Cardiology
93142001: Int.Geneeskunde - Oncologie
98342001: Medical Oncology
Afd. Interne Geneeskunde
Afdeling Oncologie / Interne Geneeskunde
Amphia
Amphia Hospital
Amphia Ziekenhuis Molengracht( #2)
Amphia Ziekenhuis, Molengracht
Amphia Ziekenhuis, Molengracht (#1)
Anaesthesia
Anesthesiology
Anesthesiology and palliative care
Cardiologie
Cardiology
Clinical Pharmacy
Department of Haematology
Department of Hematology
Department of Hospital Pharmacy
Department of medical oncology
Department of Neurology
Department of Pulmonary Diseases
Department of pulmonary diseases and center for sleep medicine
Department of Pulmonology
Department of Surgery
Dept Opthalmology
Dept Pulmonary Diseases
Dermatologie
Dermatology
Endocrinologie
gynaecologie
Gynaecology
Gynecology and obstetrics
Haematology
Hematologie
Hematology
ICU
Intensive Care
Internal Medicine
Internal Medicine - Hematology
Internal medicine – oncology hematology
Interne Geneeskunde
Interne geneeskunde/oncologie
Internist Hematology
Interventional Cardiology
Kindergeneeskunde
Longgeneeskunde
Longoncologie
Lung department
Lung Diseases
Lungdiseases (Long afdeling)
MDL
Medical Oncology
Medische Oncologie
N/A
NA
Nephrology
Neruology
Neurology
NL10011: Int.Geneeskunde - Oncologie
Obstetrics & Gynecology
Oncologie
Oncology
Oncology Center: Breast Cancer
Orthopedic Surgery
Paediatric Gastroenterology
Pediatrics
Pneumology
Pulmonary medicine
Pulmonary Science
Pulmonology
Pulmonology department
Reproductive medicine and gynecology
Research Cardiology
Respiratory Deparment
Rheumatology
Surgery
Urology
Vakgroep Maag-, Darm- en Leverziekten

Clinical trials at this site (190)

Search interface

A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A multi-centred, partially randomised, patient-preference trial of radical surgery versus adjuvant chemoradiotherapy after local excision fo… Recruiting

2024-517410-15-01 Rectal cancer 5 2025-01-14
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Recruiting

2024-510617-15-00 Non-metastatic resectable pancreatic cancer 5 2024-09-06
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
Disitamab Vedotin with Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Recruiting

2022-501105-12-00 Urothelial Carcinoma 5 2024-07-15
Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment Recruiting

2023-507481-43-00 Solid tumors 11 2024-06-25
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Recruiting

2025-522710-22-00 Cancer, bone metastasis, pain 6 2026-05-28
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Recruiting

2023-506194-35-00 Colorectal liver metastases 5 2026-05-22
eValuating the efficacy and safety of InitiatinG depemokImab earLy therApy iN COPD with Type 2 inflammation (VIGILANT) Recruiting

2025-521108-23-00 Chronic Obstructive Pulmonary Disease 5 2026-05-19
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A study to test how well PLENVU®, a bowel cleansing medicine, works in children and teenagers before they have a colonoscopy exam Recruiting

2025-522046-42-00 Colonic disease 5 2026-03-24
OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting

2025-521117-88-00 Cardiovascular Disease 5 2026-03-11
A clinical study of MK-1084 and other treatments for lung cancer (MK-1084-007) Recruiting

2024-514500-14-00 Participants with KRAS G12C-Mutant, Advanced or Metasta 5 2025-12-15
A Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518008-33-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-12
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i… Recruiting

2024-518365-10-00 Previously Untreated Advanced or Metastatic Non-Squamou 5 2025-10-28
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A clinical study of MK-1084 with targeted therapy and chemotherapy in people with colorectal cancer (MK-1084-012). Recruiting

2024-517232-22-00 KRAS G12C-mutant, Locally Advanced Unresectable or Meta 5 2025-09-26
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease. Recruiting

2024-512633-32-00 Crohn's disease 4 2025-04-07
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03
Safe Stop Trial Melanoma Recruiting

2024-516937-10-01 Melanoma 5 2024-12-18
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
Ulipristal versus surgery for symptomatic uterine fibroids Recruiting

2024-512602-26-00 Uterine fibroids 6 2024-12-02